Thomas M. McCloskey

Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.

William Bellamy, William S. Dalton, Jenai M. Kailey et al. · PubMed · 1988 · 103 citations

Medicine, Oncology, Pharmacology +16

Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration.

David S. Alberts, Earl A. Surwit, Y M Peng et al. · PubMed · 1988 · 62 citations

Medicine, Oncology, Pharmacology +16

Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma.

Patrick J. Stiff, R. Scott McKenzie, David S. Alberts et al. · Journal of Clinical Oncology · 1994 · 51 citations

Pharmacy, Oncology, Pharmacokinetics +17

Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.

Charles W. Taylor, David S. Alberts, Marsha A. Ketcham et al. · Journal of Clinical Oncology · 1989 · 45 citations

Medicine, Oncology, Pharmacology +14

High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusion

Robert T. Dorr, Margaret S. Dordal, L. Koenig et al. · Cancer · 1989 · 14 citations

Medicine, Pharmacotherapy, Surgery +15